Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

February 1, 2024

https://www.globenewswire.com/news-release/2024/02/01/2821951/0/en/Ardelyx-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-22-2024.html

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 22, 2024, at 4:30 p.m. Eastern Time to discuss fourth quarter and full year 2023 financial results and provide a business update.

Read more at globenewswire.com

Related news for (ARDX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.